The largest database of trusted experimental protocols

Signa twinspeed

Manufactured by GE Healthcare
Sourced in United States, United Kingdom

The Signa Twinspeed is a magnetic resonance imaging (MRI) system developed by GE Healthcare. It is designed to provide high-quality imaging for a wide range of clinical applications. The system features a powerful superconducting magnet and advanced radiofrequency and gradient subsystems to enable fast and efficient data acquisition.

Automatically generated - may contain errors

13 protocols using signa twinspeed

1

Cardiac MRI Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cardiac magnetic resonance scans were performed on a study‐dedicated 1.5‐T Signa Twinspeed system (GE Healthcare) using a 4‐element cardiac‐phased array coil. Typical cine steady‐state free precession scan parameters resulted in pixel dimensions of 1.8×2.1 mm, a slice thickness of 8 mm with a 3‐mm gap, and 30 images per cycle. Standard long‐axis and short‐axis views were obtained to evaluate global and regional function. End‐systolic phase was determined as the minimal cross‐sectional area of a midventricular slice. Left ventricular end diastolic volume (LVEDV) and left ventricular end systolic volume (LVESV) were computed by the summation of disks method. Left ventricular stroke volume (LVSV) in mL was calculated by subtracting LVESV from LVEDV. Left ventricular ejection fraction (LVEF) in % was calculated as LVSV/LVED×100 and cardiac output (CO) in L/min was calculated as LVSV/1000× heartbeat per minute.
+ Open protocol
+ Expand
2

Cardiac MRI Assessment of Chemotherapy Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
CMR images were acquired at 1.5 Tesla using either a Magnetom Avanto (Siemens Medical Solutions, Malvern, PA) or Signa Twinspeed (General Electric Medical Systems, Waukesha, WI) scanner. Baseline CMR examinations were performed in controls and before chemotherapy administration in patients with cancer. Six months thereafter, all participants underwent imaging with identical protocols on the same scanner used at baseline. Cardiovascular parameters assessed with CMR included LVEF, LV mass, volumes, wall thickness, sphericity index, wall stress, LV and vascular elastance, aortic distensibility, and ventricular-arterial coupling assessments. Images were analyzed by individuals blinded to temporal sequence of images, participant identifiers, and clinical data. The 21-item Minnesota Living with Heart Failure Questionnaire (MLHFQ) was administered at each CMR examination to the cancer participants to assess the impact of symptoms associated with HF.17 (link)
+ Open protocol
+ Expand
3

Evaluation of Sacroiliac Joint MRI in Pediatrics

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI examinations were performed at either 1.5 Tesla with a Signa Twinspeed or 3 Tesla Discovery 750HD scanner (General Electric Medical Systems, Milwaukee, WI) with patients placed in supine position. The following pulse sequences were obtained in an oblique coronal orientation dedicated to the SI joints: short tau inversion recovery (STIR), T1-weighted, and T1-weighted fat saturated pre- and post-gadolinium (intravenous Gd-DTPA 0.1 mmol/kg body weight) contrast enhanced images. The slice thickness was 4-5 mm; field of view = 20 cm; matrix = 512 × 512 for the T1-weighted sequence and 256 × 256 for the STIR and fat saturated T1-weighted sequences.
MR images were evaluated by a board-certified pediatric radiologist with an extra-year of fellowship training in musculoskeletal radiology and six years of post-fellowship experience. A subset of 22 MRI exams were evaluated independently by another board-certified pediatric radiologist with an additional year of fellowship training in abdominal and pelvic imaging and three years of post-fellowship experience in the interpretation of imaging examinations of pediatric bones and joints.
+ Open protocol
+ Expand
4

Brain MRI Metrics and Cerebrovascular Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
MR images were collected using 1.5T brain MRI (Signa TwinSpeed; General Electric Medical Systems). For more information on the MRI protocol, refer to [26 (link)–28 (link)]. Log-transformed white matter lesion volume and hippocampal volume, as well as the ratio of gray matter/intracranial volume (to account for correlation), and the number of cerebral microbleeds were entered as continuous predictors. The presence of infarcts (yes/no) was entered as a dichotomous variable.
+ Open protocol
+ Expand
5

MRI Acquisition Protocol for Brain Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All eligible participants were offered a high-resolution brain MRI acquired on a study-dedicated 1.5-T system (Signa Twinspeed, General Electric Medical Systems). The same imaging protocol was used in the 2002–2006 and 2007–2011 examinations, described elsewhere (21 (link), 22 (link)), and included the following sequences: 3D spoiled-gradient recalled T1-weighted, proton density/T2-weighted fast spin-echo, fluid-attenuated inversion recovery (FLAIR) and T2*-weighted gradient-echo type echoplanar (GRE-EPI). All images were acquired to give full brain coverage with slices angled parallel to the anterior commissure–posterior commissure line in order to give reproducible image views in the oblique-axial plane.
+ Open protocol
+ Expand
6

Breast MRI Protocol for Cancer Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
MR imaging was performed on a 1.5 T MRI system (Signa Twinspeed; GE Medical Systems, USA) with an eight-channel phased-array bilateral breast coil. The MRI protocol included axial T1-weighted imaging T2-weighted imaging, diffusion-weighted imaging, and DCE-MRI. Three-dimensional axial T1WI volume sequence of DCE MR imaging was performed every 58 s to scan 124 slices (TR 6 ms/TE 2.6 ms; FOV, 32 cm × 32 cm; matrix, 384 × 288; slice thickness, 2.4 mm; intersection gap, 0 mm; bandwidth, 62.5 Hz; and NEX,1). The DCE-MRI acquisitions were started after intravenous administration of 0.1 mmol/kg of Gd-DTPA (Magnevist, Bayer Schering Pharma, Germany), followed by a flush of 20 ml of saline solution with the flow of about 2 ml/s. The acquisition was repeated eight times, and each phase took 58 seconds.
+ Open protocol
+ Expand
7

MRI Protocol for Acute Optic Neuritis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Magnetic resonance imaging (MRI) of the brain and orbits were reviewed retrospectively. The MRI examinations were performed on two different scanners, a 3.0T scanner (Ingenia; Philips Healthcare, Best, the Netherlands) and a 1.5T scanner (Signa TwinSpeed; GE Healthcare), using our standard brain and orbit MRI protocols that included axial and coronal contrast-enhanced T1-weighted images with fat suppression (CE-T1W/FS), T2-weighted images with fat suppression and axial fluid-attenuation inversion recovery images (FLAIR). Enhancement of the optic nerve on CE-T1W/FS is highly sensitive for acute ON detection.
+ Open protocol
+ Expand
8

Liver MRI Contrast Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent MRI using a 3.0-T scanner (Discovery MR750; GE Healthcare, or SIGNA HDx, Little Chalfont, UK) or a 1.5-T scanner (Signa Twinspeed; GE Healthcare) with an eight-channel phased-array software coil covering the entire liver. The MRI scan sequences from both institutions are shown in Supplemental Table 1. Gadodiamide (OMNISCAN, 15 mL 4.305 g) was injected intravenously for image acquisition. Scans were conducted at 20, 60, and 180 seconds after injection to obtain arterial, portal venous, and delayed phase images (AP, PP, and DP).
+ Open protocol
+ Expand
9

MRI Segmentation and Lesion Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MRI protocol and segmentation procedure has been described elsewhere [13 (link), 28 (link)]. In short, eligible participants underwent MRI on a 1.5T Signa Twinspeed system (General Electric Medical Systems, Waukesha, WI) including a 3-dimensional axial T1-weighted spoiled gradient echo sequence, a fluid attenuated inversion recovery (FLAIR) sequence, a proton density/T2-weighted (PD/T2) fast spin echo sequence, and a T2*-weighted gradient echo type echoplanar sequence. The FLAIR, PD/T2 and T2* sequences were acquired with 3mm thick interleaved slices. Regional gray and white matter, CSF and lesions were segmented automatically with an AGES-Reykjavik Study modified algorithm described elsewhere [28 (link)]. Infarcts were rated by trained radiographers.
+ Open protocol
+ Expand
10

Orbital MRI and Ultrasonography Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Orbital MRI scans were performed using a 1.5 T MRI scanner (Signa TwinSpeed; GE Healthcare, Milwaukee, WI) with dual 7.6-mm surface coils. Spin echo T1-weighted image was carried out at a time of repetition (TR) of 600.0 ms and a time of echo (TE) of 11.1 ms. The fast spin echo T2-weighted image acquisition parameters were at TR 3000 ms and TE 120 ms. Gadopentetate dimeglumine (0.1 mmol/kg, Magnevist; Bayer Schering Pharma, Berlin, Germany) was injected and dynamic contrast-enhanced MRI were obtained employing 3D-fast spoiled gradient echo (TR 8.4 ms, TE 4.0 ms, flip angle 15°, field of view 220 × 220 mm, matrix size 256 × 160, slice thickness 3.2 mm with 0 spacing and 5 minutes acquisition time).
B-mode ultrasonography and CDFI were performed using Mylab 90× vision diagnostic instruments (Esaote, Shenzhen, China). B-type ultrasonography was used to identify the location and measure the base diameter and height of the tumor. The CM volume was calculated by the equation: V = 2лa2b/3, where V = tumor volume, a = base diameter/2, and b = height.[25 (link)] CDFI was used to observe tumor blood flow with a frequency range of 6 to 18 MHz.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!